[
["index.html", "NCA Specifications Chapter 1 NCA Specifications", " NCA Specifications Bill Denny 2018-10-17 Chapter 1 NCA Specifications "],
["introduction.html", "Chapter 2 Introduction 2.1 Scope 2.2 Out of scope", " Chapter 2 Introduction This document describes the software requirements for an R package suitable for the calculation of pharmacokinetic parameters using (pre)clinical data. 2.1 Scope The scope of the requirements is to calculate pharmacokinetic parameters: both after single-dose and multiple-dose administration; for multiple-dose administration, both at steady-state and not at steady-state; both after intravenous and extravascular administration; for intravenous, after a bolus, short-duration infusion, or continuous infusion; both plasma and excretion-related (e.g. urine and feces) measurements; with or without unscheduled samples included; after proper handling of &lt;LOQ values according to several different LOQ handling rules; after correction of deviations from nominal sampling times where possible; after substitution/imputation of missing observations where possible; after identification of data points or subjects to omit. 2.2 Out of scope At this time the validation does not include specifications to: PK parameters for breast milk, exhalation, and other more exotic measurements; sparse sample collection calculations; create any tables or figures suitable for inclusion in any document/report; perform any descriptive or comparative statistics on the calculated pharmacokinetic parameters. These specifications may be added to a future version of the requirements document. "],
["input-data.html", "Chapter 3 Input Data 3.1 SDTM Alignment 3.2 Output Data", " Chapter 3 Input Data The user must be able to define the following variables. Concentration inputs: Concentration measurement inputs: the concentration (for the examples within, below the limit of quantification, BLQ, is indicated by the value of zero) (Optional) the limit of quantification (optional) the upper limit of quantification Concentration measurement time inputs: Nominal time since first dose Nominal time since most recent dose Actual time since first dose Actual time since most recent dose Dosing inputs: Dose definition: The route of administration (e.g. “intravascular” or “extravascular”) If the data are single or multiple dose If multiple dose, if steady-state has been achieved The amount of the dose Dose time inputs (all are zero for single-dose): Nominal time since first dose Nominal time since most recent dose Actual time since first dose Actual time since most recent dose Interval inputs: the IntervalTimeRange (range of times for parameter calculations, e.g. 0 and 24 for AUC0-24); the LambdaTimeRange (range to be used for lz estimation); the length of the dosing interval (tau; this may be detected from the dosing data); Calculation inputs: how to handle loq-values (what loq-rule to be applied) flags for what datapoints and/or subjects have to be omitted 3.1 SDTM Alignment The following is intended to assist with the creation of data for testing validation and with general knowledge about SDTM. Please refer to the SDTM and ADaM standards for complete information. While not required for this standard, it is recommeded that raw data should conform to the SDTM PC domain and EX domain specifications for concentration and dosing data, when possible. Analysis data should conform to the SDTM ADAM standard as closely as feasible; when the ADAM ADNCA specification becomes standardized, this document should be revised to align with that standard. SDTM column names are not required but are preferred, and any software should detect SDTM-formatted data by default. Other standards may be used, and the minimum specifications are provided above. Concentration dataset (pc.xpt) Concentration (SDTM column: PCSTRESC or PCSTRESN) Sample time (derived from SDTM columns PCDTC, PCRFTDTC, and PCELTM) Lower limit of quantification (SDTM column: PCLLOQ) Upper limit of quantification (SDTM column: PCULOQ) Specimen collection date and time, or start of specimen collection (SDTM column: PCDTC) Specimen collection ending date and time (SDTM column: PCENDTC) Time of last dose (SDTM column: PCELTM or PCTPTNUM) 3.2 Output Data Outputs should align with the SDTM PP domain. "],
["equations.html", "Chapter 4 Equations 4.1 Defined Parameters 4.2 Parameter Table 4.3 Notes 4.4 \\(C_{min}\\) 4.5 \\(C_{trough}\\) 4.6 \\(C_{last,pred}\\) 4.7 \\(AUC_{0,t}\\), \\(AUC_{last}\\), \\(AUC_{\\tau}\\) 4.8 \\(AUC_{t_{last}-\\infty,pred}\\), \\(AUC_{t_{last}-\\infty,obs}\\) 4.9 \\(AUC_{t_{last}-\\infty,all}\\) 4.10 \\(AUC_{0-\\infty,pred}\\), \\(AUC_{0-\\infty,obs}\\) 4.11 \\(AUC_{0,all}\\) 4.12 \\(AUC_{\\%extrap,obs}\\), \\(AUC_{\\%extrap,pred}\\) 4.13 \\(F\\) 4.14 \\(AUMC_{0,t}\\), \\(AUMC_{last}\\), \\(AUMC_{\\tau}\\) 4.15 \\(AUMC_{t_{last}-\\infty,obs}\\), \\(AUMC_{t_{last}-\\infty,pred}\\) 4.16 \\(AUMC_{t_{last}-\\infty,all}\\) 4.17 \\(AUMC_{0-\\infty,obs}\\), \\(AUMC_{0-\\infty,pred}\\) 4.18 \\(AUMC_{0,all}\\) 4.19 \\(AUMC_{\\%extrap,obs}\\), \\(AUMC_{\\%extrap,pred}\\) 4.20 \\(\\lambda_z\\) 4.21 \\(N_{\\lambda_z}\\) 4.22 \\(r^2\\) 4.23 \\(r^2_{adj}\\) 4.24 \\(MRT_{ev,last}\\), \\(MRT_{ev,\\infty,obs}\\), \\(MRT_{ev,\\infty,pred}\\), \\(MRT_{iv,last}\\), \\(MRT_{iv,\\infty,obs}\\), \\(MRT_{iv,\\infty,pred}\\) 4.25 \\(MAT_{last}\\), \\(MAT_{\\infty,obs}\\), \\(MAT_{\\infty,pred}\\) 4.26 \\(R_{A,AUC}\\) 4.27 \\(R_{A,C_{max}}\\) 4.28 \\(R_{A,C_{min}}\\) 4.29 \\(R_{A,C_{trough}}\\) 4.30 \\(CL_{ev,obs}\\), \\(CL_{ev,pred}\\), \\(CL_{ev,\\tau}\\), \\(CL_{iv,obs}\\), \\(CL_{iv,pred}\\), \\(CL_{iv,\\tau}\\) 4.31 \\(V_{ss,obs}\\), \\(V_{ss,pred}\\) 4.32 \\(C_0\\) 4.33 \\(AUC_{\\%backextrap,obs}\\), \\(AUC_{\\%backextrap,pred}\\) 4.34 References", " Chapter 4 Equations For the parameter table below, concentrations measured below the limit of concentration are assumed to be written as zero. Also, mathematical terminology differs in many references; throughout this document, \\(ln\\) is used to indicate the natural logarithm (also known as the logarithm base \\(e\\), \\(log_e\\), and \\({}^elog\\)). 4.1 Defined Parameters The following parameter definitions are used throughout the parameter table, and these parameters are defined parameter (not calculated). Symbol Units Definition C concentration Concentration D amount Dose t time Time \\(\\tau\\) time Dosing interval 4.2 Parameter Table symbol units definition cdisc single multiple intravenous extravascular equation notes reference \\(C_{max}\\) concentration The maximum concentration occurring at \\(t_{max}\\). CMAX TRUE TRUE TRUE TRUE Observed \\(t_{max}\\) time The time of \\(C_{max}\\). TMAX TRUE TRUE TRUE TRUE Observed \\(C_{min}\\) concentration The minimum concentration occurring between dose time and dose time plus \\(\\tau\\) (at \\(t_{min}\\)). CMIN TRUE TRUE TRUE TRUE Observed 1 \\(t_{min}\\) time The time of \\(C_{min}\\). TMIN TRUE TRUE TRUE TRUE Observed \\(C_{trough}\\) concentration Concentration at end of dosing interval. CTROUGH TRUE TRUE TRUE TRUE Observed 2 \\(t_{lag}\\) time The time prior to the first increase in concentration. TLAG TRUE TRUE TRUE TRUE Observed (, 2013) \\(C_{last,obs}\\) concentration The last observed concentration above the limit of quantification. Equivalently, the concentration corresponding to \\(t_{last}\\). CLST TRUE TRUE TRUE TRUE Observed (, 2013) \\(C_{last,pred}\\) concentration The concentration at \\(t_{last}\\) predicted from the log-linear regression of the terminal part of the concentration-time curve (as estimated for half-life). TRUE TRUE TRUE TRUE \\[C_{last,pred} = \\lambda_z \\times t_{last} + A\\] 3 (, 2013) \\(t_{last}\\) time The time of the last measurable (positive) concentration. TLST TRUE TRUE TRUE TRUE Observed (, 2013) \\(AUC_{a,b,linear}\\) concentration*time Area under the concentration time curve from measurement at time \\(a\\) to time \\(b\\) using the linear trapezoidal rule. TRUE TRUE TRUE TRUE \\[AUC_{t_i,t_{i+1}} = \\frac{1}{2} \\left(C_i + C_{i+1}\\right) \\left(t_{i+1} - t_i\\right)\\] (, 2013) \\(AUC_{a,b,log-linear}\\) concentration*time Area under the concentration time curve from measurement at time \\(a\\) to time \\(b\\) using the log-linear trapezoidal rule. TRUE TRUE TRUE TRUE \\[AUC_{t_i,t_{i+1}} = \\frac{\\left(C_i - C_{i+1}\\right) \\left(t_{i+1} - t_i\\right)}{ln{C_i} - ln{C_{i+1}}}\\] (, 2013) \\(AUC_{0,t}\\), \\(AUC_{last}\\), \\(AUC_{\\tau}\\) concentration*time Area under the concentration time curve during a defined interval using only samples above the limit of quantification AUCINT, AUCLST, AUCTAU TRUE TRUE TRUE TRUE \\[AUC = \\sum_{t=a}^{t=min(t_{last}, b)} AUC_{t_i,t_{i+1}}\\] 4 (, 2013) \\(AUC_{t_{last}-\\infty,pred}\\), \\(AUC_{t_{last}-\\infty,obs}\\) concentration*time Area under the concentration-time curve from \\(t_{last}\\) to \\(\\infty\\) TRUE TRUE TRUE TRUE \\[\\frac{C_{last}}{\\lambda_z}\\] 5 (, 2013) \\(AUC_{t_{last}-\\infty,all}\\) concentration*time Area under the concentration-time curve from \\(t_{last}\\) to \\(\\infty\\) as used for \\(AUC_{all}\\). TRUE TRUE TRUE TRUE \\[AUC_{t_{last},t_{last+1},linear}\\] 6 (, 2013) \\(AUC_{0-\\infty,pred}\\), \\(AUC_{0-\\infty,obs}\\) concentration*time The area under the curve (AUC) extrapolated to \\(\\infty\\), calculated using the observed or predicted value of the last non-zero concentration. AUCIFP, AUCIFO TRUE FALSE TRUE TRUE \\[AUC_{last} + AUC_{t_{last}-\\infty}\\] 7 (, 2013) \\(AUC_{0,all}\\) concentration*time The area under the curve (AUC) from the time of dosing to the time of the last observation, regardless of whether the last concentration is measurable or not. AUCALL TRUE TRUE TRUE TRUE \\[AUC_{last} + AUC_{t_{last}-\\infty,all}\\] 8 (, 2013) \\(AUC_{\\%extrap,obs}\\), \\(AUC_{\\%extrap,pred}\\) % The area under the curve (AUC) from the last observed non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity using either the observed or predicted \\(C_{last}\\). AUCPEO, AUCPEP TRUE FALSE TRUE TRUE \\[\\frac{AUC_{t_{last},\\infty}}{AUC_{0,\\infty}} \\times 100\\] 9 (, 2013) \\(F\\) fraction Bioavailability TRUE FALSE TRUE TRUE \\[\\frac{AUC_{0,\\infty,ev}}{AUC_{0,\\infty,iv}} \\frac{D_{iv}}{D_{ev}}\\] \\[\\frac{AUC_{0,\\infty,test}}{AUC_{0,\\infty,reference}} \\frac{D_{reference}}{D_{test}}\\] 10 (, 2013) \\(AUMC_{a,b,linear}\\) concentration*time2 Area under the first moment of the concentration time curve from measurement at time \\(a\\) to time \\(b\\) using the linear trapezoidal rule. TRUE TRUE TRUE TRUE \\[AUMC_{t_i,t_{i+1},linear} = \\frac{1}{2} \\left(t_{i+1} - t_{i}\\right) \\left(C_{i+1} t_{i+1} + C_i t_i\\right)\\] (, 2013) \\(AUMC_{a,b,log-linear}\\) concentration*time2 Area under the first moment of the concentration time curve from measurement at time \\(a\\) to time \\(b\\) using the log-linear trapezoidal rule. TRUE TRUE TRUE TRUE \\[AUMC_{t_i,t_{i+1},log-linear} = \\frac{t_{i+1} - t_{i}}{ln\\left(C_i\\right) - ln\\left(C_{i+1}\\right)} \\left(C_{i+1} \\times t_{i+1} + C_i \\times t_i\\right) + \\\\ \\left(\\frac{t_{i+1} - t_{i}}{ln\\left(C_i\\right) - ln\\left(C_{i+1}\\right)}\\right)^2 \\left(C_i - C_{i+1}\\right)\\] (, 2013) \\(AUMC_{0,t}\\), \\(AUMC_{last}\\), \\(AUMC_{\\tau}\\) concentration*time2 Area under the first moment of the concentration time curve during a defined interval using only samples above the limit of quantification AUMCLST, AUMCTAU TRUE TRUE TRUE TRUE \\[AUMC_{last} = \\sum_{t=a}^{t=min(t_{last}, b)} AUMC_{t_i,t_{i+1}}\\] 11 (, 2013) \\(AUMC_{t_{last}-\\infty,obs}\\), \\(AUMC_{t_{last}-\\infty,pred}\\) concentration*time2 Area under the first moment of the concentration-time curve from \\(t_{last}\\) to \\(\\infty\\) TRUE TRUE TRUE TRUE \\[\\frac{C_{last} t_{last}}{\\lambda_z} + \\frac{C_{last}}{\\lambda_z^2}\\] 12 (, 2013) \\(AUMC_{t_{last}-\\infty,all}\\) concentration*time2 Area under the first moment of the concentration-time curve from \\(t_{last}\\) to \\(\\infty\\) as used for \\(AUC_{all}\\). TRUE TRUE TRUE TRUE \\[AUC_{t_{last},t_{last+1},linear}\\] 13 (, 2013) \\(AUMC_{0-\\infty,obs}\\), \\(AUMC_{0-\\infty,pred}\\) concentration*time2 Area under the first moment of the concentration-time curve extrapolated to \\(\\infty\\), calculated using the observed or predicted value of the last non-zero concentration. AUMCIFP, AUMCIFO TRUE FALSE TRUE TRUE \\[AUMC_{last} + AUMC_{t_{last}-\\infty}\\] 14 (, 2013) \\(AUMC_{0,all}\\) concentration*time2 Area under the first moment of the concentration-time curve from the time of dosing to the time of the last observation, regardless of whether the last concentration is measurable or not. TRUE TRUE TRUE TRUE \\[AUMC_{last} + AUMC_{t_{last}-\\infty,all}\\] 15 (, 2013) \\(AUMC_{\\%extrap,obs}\\), \\(AUMC_{\\%extrap,pred}\\) % Area under the first moment of the concentration-time curve from the last observed non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity using either the observed or predicted \\(C_{last}\\). AUMCPEO, AUMCPEP TRUE FALSE TRUE TRUE \\[\\frac{AUMC_{t_{last}-\\infty}}{AUMC_{0,\\infty}} \\times 100\\] 16 (, 2013) \\(t_{1/2}\\) time Terminal half-life LAMZHL TRUE TRUE TRUE TRUE \\[\\frac{ln 2}{\\lambda_z}\\] (, 2013) \\(\\lambda_z\\) 1/time The first order rate constant associated with the terminal (log-linear) portion of the curve. LAMZ TRUE TRUE TRUE TRUE \\[ln C = A - \\lambda_z t\\] 17 (, 2013) \\(t_{first,\\lambda_z}\\), \\(t_{last,\\lambda_z}\\) time The first and last time (lower and upper limit on time) for values to be included in the calculation of \\(\\lambda_z\\). LAMZLL, LAMZUL TRUE TRUE TRUE TRUE (, 2013) \\(N_{\\lambda_z}\\) count The number of time points used in computing \\(\\lambda_z\\). LAMZNPT TRUE TRUE TRUE TRUE 18 \\(r^2\\) fraction The goodness of fit statistic for the terminal elimination phase. R2 TRUE TRUE TRUE TRUE \\[1 - \\frac{\\sum_i \\left(C_i - \\hat{C_i}\\right)^2}{\\sum_i \\left(C_i - \\overline{C_i}\\right)^2}\\] 19 \\(r^2_{adj}\\) fraction The goodness of fit statistic for the terminal elimination phase, adjusted for the number of time points used in the estimation of \\(\\lambda_z\\). R2ADJ TRUE TRUE TRUE TRUE \\[1 - \\left(1 - r^2\\right) \\frac{1}{N_{\\lambda_z}-2}\\] 20 (, 2013) \\(MRT_{ev,last}\\), \\(MRT_{ev,\\infty,obs}\\), \\(MRT_{ev,\\infty,pred}\\), \\(MRT_{iv,last}\\), \\(MRT_{iv,\\infty,obs}\\), \\(MRT_{iv,\\infty,pred}\\) time Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration or infinity, for a substance administered by intravascular or extravascular dosing. MRTEVLST, MRTEVIFO, MRTEVIFP, MRTIVLST, MRTIVIFO, MRTIVIFP TRUE TRUE TRUE TRUE \\[\\frac{AUMC}{AUC}\\] 21 (, 2013) \\(MAT_{last}\\), \\(MAT_{\\infty,obs}\\), \\(MAT_{\\infty,pred}\\) time Mean absorption time of a substance administered by extravascular dosing. MAT TRUE TRUE FALSE TRUE \\[MRT_{ev} - MRT{iv}\\] \\[t_{lag} + \\frac{1}{K_a}\\] 22 (, 2013) \\(PTR\\) ratio The maximum concentration during a dosing interval divided by the concentration at the end of the dosing interval. PTROUGHR FALSE TRUE TRUE TRUE \\[\\frac{C_{max}}{C_{trough}}\\] (, 2013) \\(TPR\\) ratio The concentration at the start of a dosing interval divided by the maximum concentration during the dosing interval. TROUGHPR FALSE TRUE TRUE TRUE \\[\\frac{C_{trough}}{C_{max}}\\] \\(PTF\\) % The difference between Cmin and Cmax standardized to Cavg, between dose time and \\(\\tau\\). FLUCP FALSE TRUE TRUE TRUE \\[100 \\times \\frac{C_{max} - C_{min}}{C_{avg}}\\] (, 2013) \\(C_{avg}\\), \\(C_{av}\\) concentration Average concentration CAVG FALSE TRUE TRUE TRUE \\[\\frac{AUC_{0,\\tau}}{\\tau}\\] (, 2013) \\(R_{A,AUC}\\) fraction The area under the curve at steady state divided by the area under the curve over the initial dosing interval. ARAUC FALSE TRUE TRUE TRUE \\[R_{A,AUC} = \\frac{AUC_{\\tau,ss}}{AUC_{\\tau,sd}}\\] 23 (, 2013) \\(R_{A,C_{max}}\\) fraction The maximum concentration at steady state divided by the maximum concentration during the initial dosing interval. ARCMAX FALSE TRUE TRUE TRUE \\[R_{A,C_{max}} = \\frac{C_{max,ss}}{C_{max,sd}}\\] 24 (, 2013) \\(R_{A,C_{min}}\\) fraction The minimum concentration at steady state divided by the minimum concentration during the initial dosing interval. ARCMIN FALSE TRUE TRUE TRUE \\[R_{A,C_{min}} = \\frac{C_{min,ss}}{C_{min,sd}}\\] 25 (, 2013) \\(R_{A,C_{trough}}\\) fraction The trough concentration at steady state divided by the trough concentration during the initial dosing interval. ARCTROUG FALSE TRUE TRUE TRUE \\[R_{A,C_{trough}} = \\frac{C_{trough,ss}}{C_{trough,sd}}\\] 26 (, 2013) \\(CL_{ev,obs}\\), \\(CL_{ev,pred}\\), \\(CL_{ev,\\tau}\\), \\(CL_{iv,obs}\\), \\(CL_{iv,pred}\\), \\(CL_{iv,\\tau}\\) volume/time The total body clearance for extravascular or intravascular administration (divided by the fraction of dose absorbed for extravascular), calculated using the equivalent \\(AUC\\). CLFO, CLFP, CLFTAU, CLO, CLP, CLTAU TRUE TRUE TRUE TRUE \\[\\frac{F \\times D}{AUC}\\] 27 (, 2013) \\(V_{ss,obs}\\), \\(V_{ss,pred}\\) volume The volume of distribution at steady state based on the equivalent for a substance administered by intravascular dosing. VSSO, VSSP TRUE FALSE TRUE FALSE \\[CL \\times MRT\\] \\[\\frac{F \\times D \\times AUMC}{AUC^2}\\] 28 (, 2013) \\(V_{z,ev,obs}\\), \\(V_{z,ev,pred}\\), \\(V_{z,ev,\\tau}\\), \\(V_{z,iv,obs}\\), \\(V_{z,iv,pred}\\), \\(V_{z,iv,\\tau}\\) volume The volume of distribution associated with the terminal slope following extravascular or intravascular administration (divided by the fraction of dose absorbed for extravascular), calculated using equivalent \\(AUC\\). VZFO, VZFP, VZFTAU, VZO, VZP, VZTAU TRUE TRUE TRUE TRUE \\[\\frac{F \\times D}{AUC \\times \\lambda_z}\\] (, 2013) \\(C_0\\) concentration Initial concentration C0 TRUE TRUE TRUE FALSE 29 \\(V_0\\) volume The initial volume of distribution for a substance administered by bolus intravascular dosing. V0 TRUE FALSE TRUE FALSE \\[\\frac{D}{C_0}\\] (, 2013) \\(AUC_{\\%backextrap,obs}\\), \\(AUC_{\\%backextrap,pred}\\) concentration*time TRUE TRUE TRUE FALSE \\[\\frac{AUC_{0,first}}{AUC_{0,\\infty}}\\] 30 4.3 Notes 4.4 \\(C_{min}\\) Compare with \\(C_{trough}\\). 4.5 \\(C_{trough}\\) Compare with \\(C_{min}\\). 4.6 \\(C_{last,pred}\\) Parameters in the equation are fit during half-life fitting. 4.7 \\(AUC_{0,t}\\), \\(AUC_{last}\\), \\(AUC_{\\tau}\\) Often, the \\(AUC_{a,b,linear}\\) and \\(AUC_{a,b,log-linear}\\) are combined where the linear trapezoidal rule is used for ascending concentrations (\\(C_{i+1} &gt;= C_i\\)) or when the next concentration is below the limit of quantification (\\(C_{i+1} &gt; 0\\), if applicable), and the log-linear trapezoidal rule is used for descending concentrations \\(C_{i+1} &lt; C_i\\). 4.8 \\(AUC_{t_{last}-\\infty,pred}\\), \\(AUC_{t_{last}-\\infty,obs}\\) \\(C_{last}\\) should be \\(C_{last,pred}\\) or \\(C_{last,obs}\\) depending on which version of the parameter is desired. 4.9 \\(AUC_{t_{last}-\\infty,all}\\) \\(t_{last+1}\\) is the first time point below the limit of quantification. 4.10 \\(AUC_{0-\\infty,pred}\\), \\(AUC_{0-\\infty,obs}\\) Use the ‘pred’ or ‘obs’ version of \\(AUC_{t_{last}-\\infty}\\) for the equivalent version of \\(AUC_{0-\\infty}\\). 4.11 \\(AUC_{0,all}\\) If all concentrations are above the limit of quantification, then \\(AUC_{0,all}=AUC_{last}\\). 4.12 \\(AUC_{\\%extrap,obs}\\), \\(AUC_{\\%extrap,pred}\\) Use the ‘pred’ or ‘obs’ version of \\(AUC_{t_{last},\\infty}\\) and \\(AUC_{0,\\infty}\\) for the equivalent version of \\(AUC_{\\%extrap}\\). 4.13 \\(F\\) Bioavailability is the ratio of two AUC values. In addition to the comparison of extravascular (\\(ev\\)) to intravascular (\\(iv\\)) for absolute bioavailability, relative bioavailability compares any two \\(AUC_{0,\\infty} values, a &#39;test&#39; to a &#39;reference&#39;\\). In some cases, bioavailability may be tested at steady-state using \\(AUC_{0,\\tau}\\) instead of \\(AUC_{0,\\infty}\\). 4.14 \\(AUMC_{0,t}\\), \\(AUMC_{last}\\), \\(AUMC_{\\tau}\\) See \\(AUC_{last}\\) notes for suggested calculation options. 4.15 \\(AUMC_{t_{last}-\\infty,obs}\\), \\(AUMC_{t_{last}-\\infty,pred}\\) \\(C_{last}\\) should be \\(C_{last,pred}\\) or \\(C_{last,obs}\\) depending on which version of the parameter is desired. 4.16 \\(AUMC_{t_{last}-\\infty,all}\\) \\(t_{last+1}\\) is the first time point below the limit of quantification. 4.17 \\(AUMC_{0-\\infty,obs}\\), \\(AUMC_{0-\\infty,pred}\\) Use the ‘obs’ or ‘pred’ version of \\(AUC_{t_{last}-\\infty}\\) for the equivalent version of \\(AUC_{0-\\infty}\\). 4.18 \\(AUMC_{0,all}\\) If all concentrations are above the limit of quantification, then \\(AUMC_{0,all}=AUMC_{last}\\). 4.19 \\(AUMC_{\\%extrap,obs}\\), \\(AUMC_{\\%extrap,pred}\\) Use the ‘pred’ or ‘obs’ version of \\(AUMC_{t_{last}-\\infty}\\) for the equivalent version of \\(AUMC_{0-\\infty}\\). 4.20 \\(\\lambda_z\\) Fit the equation using observed concentration (\\(C\\)) and time (\\(t\\)) from the terminal slope of the concentration-time curve. Selection of points for inclusion may be either manual or regression-quality based. 4.21 \\(N_{\\lambda_z}\\) \\(N_{\\lambda_z}\\) should always be greater than or equal to 3. 4.22 \\(r^2\\) \\(r^2\\) is typically directly available from line-fitting functions and rarely requires direct calculation. \\(\\overline{C_i}\\) is the mean concentration of values used; \\(\\hat{C_i}\\) is the estimated concentation. 4.23 \\(r^2_{adj}\\) The canonical form of \\(r^2_{adj}\\) has the fraction on the right of the equation as \\(\\frac{p}{n-p-1}\\), but for fitting terminal regression \\(p=1\\). 4.24 \\(MRT_{ev,last}\\), \\(MRT_{ev,\\infty,obs}\\), \\(MRT_{ev,\\infty,pred}\\), \\(MRT_{iv,last}\\), \\(MRT_{iv,\\infty,obs}\\), \\(MRT_{iv,\\infty,pred}\\) The equation shown here includes the mean absorption time for extravascular administration aligning with the SDTM definition. The \\(AUMC\\) and \\(AUC\\) should be chosen to match the parameter type desired (e.g. use \\(AUMC_{last}\\) and \\(AUC_{last}\\) for \\(MRT_{last}\\)). 4.25 \\(MAT_{last}\\), \\(MAT_{\\infty,obs}\\), \\(MAT_{\\infty,pred}\\) \\(K_a\\) is the absorption rate from multi-exponential compartmental analysis curve fitting (and is not typically applicable for noncompartmental analysis). 4.26 \\(R_{A,AUC}\\) \\(ss\\) indicates that value is at steady-state while \\(sd\\) indicated that value is from the first (single) dose. 4.27 \\(R_{A,C_{max}}\\) \\(ss\\) indicates that value is at steady-state while \\(sd\\) indicated that value is from the first (single) dose. 4.28 \\(R_{A,C_{min}}\\) \\(ss\\) indicates that value is at steady-state while \\(sd\\) indicated that value is from the first (single) dose. 4.29 \\(R_{A,C_{trough}}\\) \\(ss\\) indicates that value is at steady-state while \\(sd\\) indicated that value is from the first (single) dose. 4.30 \\(CL_{ev,obs}\\), \\(CL_{ev,pred}\\), \\(CL_{ev,\\tau}\\), \\(CL_{iv,obs}\\), \\(CL_{iv,pred}\\), \\(CL_{iv,\\tau}\\) For each of the symbols, select the equivalent \\(AUC\\). Such as, \\(CL_{ev,pred}\\) uses \\(AUC = AUC_{0,\\infty,pred}\\) 4.31 \\(V_{ss,obs}\\), \\(V_{ss,pred}\\) SDTM parameters are specific to intravascular dosing. For each of the symbols, select the equivalent \\(AUMC\\) and \\(AUC\\). When extravascular dosing is used, it is referred to as the observed or apparent volume of distribution at steady-state. CL and MRT may be given either for single dosing with \\(AUC_{0,\\infty}\\) or steady-state with \\(AUC_{0,\\tau}\\). 4.32 \\(C_0\\) IV bolus only. \\(C_0\\) is back-extrapolated from the first two data points after the infusion. See data cleaning rules SDC-4 and MDC-4 for more details on the calculation and cleaning associated with \\(C_0\\). 4.33 \\(AUC_{\\%backextrap,obs}\\), \\(AUC_{\\%backextrap,pred}\\) IV bolus only. \\(first\\) is the first time point after 0, and both \\(AUC\\) values should be calculated with \\(C_0\\) included at time 0. 4.34 References [1] Microsoft Word - PK-glossary_ PK_ working_ group_2004.doc. &lt;URL: http://www.agah.eu/fileadmin/_migrated/content_uploads/PK-glossary_PK_working_group_2004.pdf&gt;. 2013. &lt;URL: http://www.agah.eu/fileadmin/_migrated/content_uploads/PK-glossary_PK_working_group_2004.pdf&gt;. "],
["test-cases.html", "Chapter 5 Test Cases 5.1 Introduction 5.2 Examples", " Chapter 5 Test Cases 5.1 Introduction For each of the parameters, at least one test case will be given below. The test cases are intended to be structured so that they test the underlying calculation in all reasonable scenarios including with a variety of algorithm choices. The test cases are also structured so that they are easily usable by any software package with standardized naming of the concentration-time datasets, the algorithm selections, and the results. All inputs and outputs are structured to be as simple as possible while being similar to CDISC SDTM standards. The simplicity is used to enable as many software packages to test against the tests without requiring implementation or understanding of the full CDISC SDTM standard. The examples along with the current version of this document can be obtained at the NCA Consortium GitHub Page. 5.2 Examples (Examples including concentration-time data and calculation of all relevant parameters are planned here.) "],
["deviations.html", "Chapter 6 Deviations 6.1 Introduction 6.2 Limit of Quantification Modifications 6.3 Time Deviation Correction Rules 6.4 Concentration Deviation Correction Rules 6.5 Interpolation 6.6 Extrapolation", " Chapter 6 Deviations 6.1 Introduction Time and concentration deviations may require correction prior to completing final NCA calculations. This section describes methods used for corrections and the associated calculations to be performed prior to final calculations. 6.2 Limit of Quantification Modifications At least one of the following rules must be implemented for handling concentrations below the limit of quantification (BLOQ). Different rules may be implemented for the predose concentration measurement, concentrations before the first concentration above the LOQ, BLOQ concentrations between the concentrations above the LOQ, and after the last concentration above the LOQ. Rule Number Short description Description LOQ-1 Exclude Exclude any BLOQ value. (LOQ-1 is the typical default.) LOQ-2 Set 0 Set BLOQ values to 0. LOQ-3 Set half-LOQ then exclude Set first BLOQ value to \\(0.5 \\times LOQ\\), exclude subsequent BLOQ values. LOQ-4 Set half-LOQ then 0 Set first BLOQ value to \\(0.5 \\times LOQ\\), set subsequent BLOQ values to 0. LOQ-5 Set half-LOQ Set BLOQ values to \\(0.5 \\times LOQ\\). 6.3 Time Deviation Correction Rules The time deviation correction rules have to be applied in cases where the actual sampling time deviates from the nominal time at t=0 (all AUCs), t=t_upper (AUCINT) and/or t=TAU (AUCTAU). DOSING RULE NUMBER DESCRIPTION PARAMETER Single Dose (SD) SDT-1 set actual time to 0 t0 Single Dose (SD) SDT-2 correct concentration at deviating time by interpolation t_upper Single Dose (SD) SDT-3 correct concentration at deviating time by extrapolation t_upper Multiple Dose (MD) MDT-1 at predose, if sample taken after dosing, add a row t=0 and c=NA t0 Multiple Dose (MD) MDT-2 correct concentration at deviating time by interpolation t_upper, tau Multiple Dose (MD) MDT-3 correct concentration at deviating time by extrapolation t0, t_upper, tau 6.4 Concentration Deviation Correction Rules Concentration substitution rules have to be applied where the concentration is missing at t=0 (all AUCs), t=t_upper (AUCINT) and/or t=TAU (AUCTAU). DOSING RULE NUMBER DESCRIPTION PARAMETER Single Dose (SD) SDC-1 set concentration to 0 (only for non-endogenous compounds) t0 Single Dose (SD) SDC-2 impute missing concentration by interpolation t_upper, TAU Single Dose (SD) SDC-3 impute missing concentration by extrapolation t_upper, TAU Single Dose (SD) SDC-4 Bolus IV: impute concentration at C0 by back-extrapolation using the first two observations. If the resulting slope is positive or one of both concentrations is LOQ or NA, the first non-zero concentration is used as C0. t0 Multiple Dose (MD) MDC-1 impute missing conc. by existing conc. at t0 or TAU (only if steady state has been reached) t0, TAU Multiple Dose (MD) MDC-2 impute missing concentration by interpolation t_upper, TAU Multiple Dose (MD) MDC-3 impute missing concentration by extrapolation t_upper, TAU Multiple Dose (MD) MDC-4 Bolus IV: impute concentration at C0 by back-extrapolation using the first two observations. If the resulting slope is positive or one of both concentrations is LOQ or NA, the first non-zero concentration is used as C0 t0 6.5 Interpolation To obtain a concentration (\\(C_i\\)) at time i (\\(t_i\\)), lying between the times \\(t_a\\) and \\(t_b\\) with concentrations \\(C_a\\) and \\(C_b\\) respectively, and no dose occurring between \\(t_a\\) and \\(t_b\\) interpolation will be carried out. Multiple methods of interpolation are possible, and the method of interpolation should align with the method for calculation of area under the concentration-time curve (AUC). 6.5.1 Zero Interpolation If \\(C_a\\) and \\(C_b\\) are BLOQ, \\(C_i\\) should be set to BLOQ. 6.5.2 Linear Interpolation If linear AUC integration is used in the interval between \\(t_a\\) and \\(t_b\\) (trapezoidal rule AUC calculation or linear-up/log-down AUC with \\(C_b \\geq C_a\\)), the following formula should be used. \\[C_i = C_a + \\left(C_b-C_a\\right)\\frac{t_i-t_a}{t_b-t_a}\\] 6.5.3 Log-Linear Interpolation If log-linear AUC integration is used in the interval between \\(t_a\\) and \\(t_b\\) (linear-up/log-down AUC with \\(C_b &lt; C_a\\)), the following formula should be used. \\[C_i = exp\\left( log\\left(C_a\\right) + \\left(log\\left(C_b\\right) - log\\left(C_a\\right)\\right) \\frac{t_i - t_a}{t_b - t_a} \\right)\\] 6.6 Extrapolation To extrapolate a concentration \\(C_i\\) at time \\(t_i\\) lying after a time \\(t_a\\) with measurable concentration \\(C_a\\) and no dose occurring between \\(t_a\\) and \\(t_i\\), the following formula should be used. \\[C_i = C_a exp\\left(-\\lambda_z \\times \\left(t_i - t_a\\right)\\right)\\] where \\(\\lambda_z\\) is the elimination rate constant and it must be positive. It is calculated during calculation of the half-life (\\(t_{1/2}\\)), and is calculable from half-life as \\(\\lambda_z=\\frac{log_e(2)}{t_{1/2}}\\). "],
["deviation-examples.html", "Chapter 7 Deviation Examples", " Chapter 7 Deviation Examples "],
["sdt.html", "Chapter 8 SDT 8.1 SDT-1 8.2 SDT-2 8.3 SDT-3", " Chapter 8 SDT 8.1 SDT-1 ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 8.2 SDT-2 ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 8.3 SDT-3 ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead "],
["mdt.html", "Chapter 9 MDT 9.1 MDT-1 9.2 MDT-2 9.3 MDT-3", " Chapter 9 MDT 9.1 MDT-1 ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 9.2 MDT-2 ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 9.3 MDT-3 ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead "],
["sdc.html", "Chapter 10 SDC 10.1 SDC-1 10.2 SDC-2 10.3 SDC-3 10.4 SDC-4a 10.5 SDC-4b 10.6 SDC-4c 10.7 SDC-4d", " Chapter 10 SDC 10.1 SDC-1 ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 10.2 SDC-2 ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 10.3 SDC-3 ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 10.4 SDC-4a ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 10.5 SDC-4b ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 10.6 SDC-4c ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 10.7 SDC-4d ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead "],
["mdc.html", "Chapter 11 MDC 11.1 MDC-1 11.2 MDC-2 11.3 MDC-3 11.4 MDC-4a 11.5 MDC-4b 11.6 MDC-4c 11.7 MDC-4d", " Chapter 11 MDC 11.1 MDC-1 ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 11.2 MDC-2 ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 11.3 MDC-3 ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 11.4 MDC-4a ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 11.5 MDC-4b ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 11.6 MDC-4c ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead 11.7 MDC-4d ## Warning: `panel.margin` is deprecated. Please use `panel.spacing` property ## instead "],
["session-information.html", "Chapter 12 Session Information", " Chapter 12 Session Information sessionInfo() ## R version 3.5.1 (2018-07-02) ## Platform: x86_64-apple-darwin15.6.0 (64-bit) ## Running under: macOS High Sierra 10.13.6 ## ## Matrix products: default ## BLAS: /Library/Frameworks/R.framework/Versions/3.5/Resources/lib/libRblas.0.dylib ## LAPACK: /Library/Frameworks/R.framework/Versions/3.5/Resources/lib/libRlapack.dylib ## ## locale: ## [1] en_US.UTF-8/en_US.UTF-8/en_US.UTF-8/C/en_US.UTF-8/en_US.UTF-8 ## ## attached base packages: ## [1] stats graphics grDevices utils datasets methods base ## ## other attached packages: ## [1] cowplot_0.9.3 ggplot2_3.0.0 dplyr_0.7.6 ## ## loaded via a namespace (and not attached): ## [1] Rcpp_0.12.19 knitr_1.20 bindr_0.1.1 magrittr_1.5 ## [5] munsell_0.5.0 tidyselect_0.2.5 colorspace_1.3-2 R6_2.3.0 ## [9] rlang_0.2.2 plyr_1.8.4 stringr_1.3.1 tools_3.5.1 ## [13] grid_3.5.1 gtable_0.2.0 xfun_0.3 withr_2.1.2 ## [17] htmltools_0.3.6 lazyeval_0.2.1 yaml_2.2.0 rprojroot_1.3-2 ## [21] digest_0.6.18 assertthat_0.2.0 tibble_1.4.2 crayon_1.3.4 ## [25] bookdown_0.7 bindrcpp_0.2.2 reshape2_1.4.3 purrr_0.2.5 ## [29] glue_1.3.0 evaluate_0.12 rmarkdown_1.10 labeling_0.3 ## [33] stringi_1.2.4 compiler_3.5.1 pillar_1.3.0 scales_1.0.0 ## [37] backports_1.1.2 pkgconfig_2.0.2 "]
]
